Transforming MIGS in More Ways Than One
iStent inject® represents the next generation of Glaukos trabecular micro-bypass technology, which has been proven safe and effective in hundreds of thousands of eyes worldwide. iStent inject® creates two patent bypass pathways through the trabecular meshwork, resulting in multi-directional flow through Schlemm’s canal, and is advancing the standard of care for glaucoma patients.Learn More
Our Comprehensive Support. Your Uncompromising Patient Care.
Integrating iStent inject® into your practice helps you expand care, and provide a wider range of benefits to many of your patients. As a trusted industry leader—and the corporate founder of MIGS—we have the experience, tools, and training to make integration easy.Learn More